RADIATION THERAPY ONCOLOGY GROUP
RTOG 0926
A PHASE II PROTOCOL FOR PATIENTS WITH STAGE T1 BLADDER CANCER TO EVALUATE SELECTIVE BLADDER PRESERVING TREATMENT BY RADIATION THERAPY CONCURRENT WITH CISPLATIN CHEMOTHERAPY FOLLOWING A THOROUGH TRANSURETHRAL SURGICAL RE-STAGING
RTOG 0926
A PHASE II PROTOCOL FOR PATIENTS WITH STAGE T1 BLADDER CANCER TO EVALUATE SELECTIVE BLADDER PRESERVING TREATMENT BY RADIATION THERAPY CONCURRENT WITH CISPLATIN CHEMOTHERAPY FOLLOWING A THOROUGH TRANSURETHRAL SURGICAL RE-STAGING
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire
- Download Forms (only Part I is required for this protocol)
- Submit to RTOG
- How to Participate
- Structure Names - Please refer to protocol text for structure naming requirements.
- Protocol Text (http://www.rtog.org/)
PLEASE NOTE: As of 12/17/13, this protocol has been amended to require treatment planning data submission via the TRIAD system. Cases with case numbers above 15 are to be submitted via TRIAD at RTOG HQ. Please see section 12.2 of the protocol for information on TRIAD.
Back to protocols
